CLINICAL TRIALS PROFILE FOR NIMODIPINE
✉ Email this page to a colleague
All Clinical Trials for nimodipine
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000280 ↗ | Glutaminergic Agents for Cocaine Abuse - 5 | Completed | National Institute on Drug Abuse (NIDA) | Phase 1 | 1994-09-01 | The purpose of this study is to evaluate glutaminergic agents for cocaine abuse. |
NCT00000280 ↗ | Glutaminergic Agents for Cocaine Abuse - 5 | Completed | VA Connecticut Healthcare System | Phase 1 | 1994-09-01 | The purpose of this study is to evaluate glutaminergic agents for cocaine abuse. |
NCT00000280 ↗ | Glutaminergic Agents for Cocaine Abuse - 5 | Completed | Yale University | Phase 1 | 1994-09-01 | The purpose of this study is to evaluate glutaminergic agents for cocaine abuse. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for nimodipine
Condition Name
Clinical Trial Locations for nimodipine
Trials by Country
Clinical Trial Progress for nimodipine
Clinical Trial Phase
Clinical Trial Sponsors for nimodipine
Sponsor Name